Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Effect of Intravenous Dexmedetomidine Versus Intravenous Lidocaine on the Emergence Agitation After Endoscopic Sinus Surgery
NCT07355049Not yet recruiting
- Sponsor
- Fayoum University
- Start
- Dec 2025
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine and Lidocaine Hydrochloride Injection, without epinephrine in Emergence agitation (EA) (2 arms), sponsored by Fayoum University. Primary endpoint: Incidence of emergence agitation. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
dexmedetomidineLidocaine Hydrochloride Injection, without epinephrine
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on NCT07355049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07355049.